c
MEDIA, JOBS & RESOURCES FOR THE COMMON GOOD
NEWS  |  Corporate Engagement, Good Business

Wesfarmers Donate to Women’s Cancer Research


Tuesday, 25th November 2014 at 3:03 pm
Lina Caneva, Editor
A donation of $5 million from one of Australia's largest listed companies Wesfarmers is set to have a major impact on women’s cancer research in Western Australia.

Tuesday, 25th November 2014
at 3:03 pm
Lina Caneva, Editor


0 Comments


FREE SOCIAL
SECTOR NEWS

 Print
Wesfarmers Donate to Women’s Cancer Research
Tuesday, 25th November 2014 at 3:03 pm

A donation of $5million from one of Australia's largest listed companies Wesfarmers is set to have a major impact on women’s cancer research in Western Australia.

The Chairman of the Harry Perkins Institute of Medical Research, Laurence Iffla, says Wesfarmers has donated $5 million to establish Western Australia’s first Professorial Chair in Women’s Cancers.

Wesfarmers which owns Coles, Target and Kmart was set up the company in 1914 as a Western Australian farmers' cooperative.

“This gift will enable the appointment of an outstanding scientist to lead the new Perkins Centre for Women’s Cancer Research,” Iffla said.

The Director of the Harry Perkins Institute of Medical Research, Professor Peter Leedman, said the centre would focus on defeating two of the most challenging diseases facing women:  breast cancer and ovarian cancer.

“One in eight Australian women will be diagnosed with breast cancer,” Professor Leedman said.

“As a result of medical research, survival rates for women with breast cancer have increased but more work is urgently needed, particularly on “triple negative” breast cancer, the cancer for which there is currently no successful targeted treatment.

“For the thousands of women who suffer from the “silent killer”, ovarian cancer, the future is bleak.  With a survival rate of less than 20 per cent, cancer of the ovary is the most prevalent, and lethal, form of gynaecological cancer.

“Further discovery-based medical research will result in more effective and targeted treatments,” Professor Leedman said.

The Institute will soon advertise for a leading researcher to fill the Wesfarmers Chair in Women’s Cancers position.

The Harry Perkins Institute for Medical Research aims to  improve the health of Western Australians through cutting edge research that translates into new ways to prevent and treat disease. The cancers under study include breast, prostate, melanoma, colon, head and neck, liver and leukaemia.


Lina Caneva  |  Editor |  @ProBonoNews

Lina Caneva has been a journalist for more than 35 years, and Editor of Pro Bono Australia News since it was founded in 2000.

FEATURED SUPPLIERS


Prolegis Lawyers work exclusively for charities, other not-f...

Prolegis Lawyers

Yes we’re lawyers, but we do a lot more....

Moores

Brennan IT helps not-for-profit (NFP) organisations drive gr...

Brennan IT

Fantastic digital management app for organisations deliverin...

Ateesa

More Suppliers

Get more stories like this

FREE SOCIAL
SECTOR NEWS

YOU MAY ALSO LIKE

Governance for Deductible Gift Recipients

Contributor

Tuesday, 12th December 2017 at 8:25 am

Perth Convention Bureau Hosts Aspire Program Free Information Event

Contributor

Tuesday, 14th November 2017 at 8:18 am

Five Ways The Future of Work Could Change For Women

Victoria George

Friday, 27th October 2017 at 4:13 pm

POPULAR

Luke Batty Foundation to Close as Rosie Batty Steps Down

Luke Michael

Monday, 19th February 2018 at 5:37 pm

Australians Losing Trust in Charities

Wendy Williams

Wednesday, 7th February 2018 at 5:28 pm

Calls to Remove ‘Blanket Religious Exemptions’ for Faith-Based Charities

Luke Michael

Friday, 16th February 2018 at 2:35 pm

Prisoners with Disability Subject to Harrowing Abuse, Report Finds

Luke Michael

Wednesday, 7th February 2018 at 4:19 pm

Write a Reply or Comment

Your email address will not be published. Required fields are marked *


c
pba inverse logo
Subscribe Twitter Facebook

Get the social sector's most essential news coverage. Delivered free to your inbox every Tuesday and Thursday morning.

You have Successfully Subscribed!